Tim Avis
Impact in
-
- Antibiotic Use and Resistance
-
- Antibiotic Resistance in Bacteria
Papers in
-
- DNA Repair Mechanisms 2
- Gut microbiota and health 2
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Clive Mason (5 shared papers)Nawaz Khan (3 shared papers)David J. Powell (3 shared papers)Francis X. Wilson (1 shared paper)Elena B. M. Breidenstein (2 shared papers)Nabeetha Nagalingam (2 shared papers)Thomas P. Duffy (1 shared paper)Luís F. de Figueiredo (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Open Forum Infectious Diseases (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Tim Avis
7 papers receiving 52 citations
Peers
Comparison fields: 5 of 44
- Applied Microbiology and Biotechnology 9
- Molecular Medicine 16
- Endocrinology 3
- Microbiology 3
- Molecular Biology 28
Countries citing papers authored by Tim Avis
This map shows the geographic impact of Tim Avis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Avis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Avis more than expected).
Fields of papers citing papers by Tim Avis
This network shows the impact of papers produced by Tim Avis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Avis. The network helps show where Tim Avis may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Avis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 28 | |
| 2 | 2023 | 10 | |
| 3 | 2020 | 5 | |
| 4 | 2009 | 5 | |
| 5 | 2023 | 5 | |
| 6 | Abstract #5494: Pre-clinical evaluation of single-agent activity of the PARP inhibitor olaparib (AZD2281) in homologous recombination deficient triple-negative breast cancer | 2009 | 1 |
| 7 | 2010 | 1 | |
| 8 | 2021 | 0 |
About Tim Avis
Tim Avis is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Genetics and Epidemiology, having authored 8 papers that have together received 55 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (3 papers), PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Gut microbiota and health (2 papers), Genetic factors in colorectal cancer (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (9 citations), Molecular Medicine (16 citations), Endocrinology (3 citations), Microbiology (3 citations) and Molecular Biology (28 citations). Tim Avis has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Clive Mason, Nawaz Khan, David J. Powell, Francis X. Wilson, Elena B. M. Breidenstein, Nabeetha Nagalingam, Thomas P. Duffy, Luís F. de Figueiredo, Ondrej Kalous and Tim French. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Cancer Research, Molecular Cancer Therapeutics, Open Forum Infectious Diseases and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.